Email this page
Print
Bookmark and share
Bigger
Smaller
Download PDF
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
NPS RADAR April 2008NPS RADAR April 2008
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Find out more about NPS RADAR.
| Title | Why read this |
|---|---|
| NPS RADAR April 2008 Professional publication - NPS RADAR - Complete issue | NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals. |
| Methylphenidate (Ritalin LA): a second controlled-release formulation PBS listed for attention deficit hyperactivity disorder Professional publication - NPS RADAR - Brief item | A second controlled-release formulation of methylphenidate (Ritalin LA) was listed on the PBS to be prescribed for patients aged 6 to 18 years inclusive for attention deficit hyperactivity disorder (ADHD). |
| Smaller dose volume of influenza vaccine PBS listed for children aged 6-35 months Professional publication - NPS RADAR - Brief item | A smaller dose volume (0.25 mL) of influenza vaccine has been PBS listed for children aged 6-35 months who are at risk of adverse outcomes from lower respiratory tract infections. |
| Terbinafine authority listed for fungal infections in Aboriginal and Torres Strait Islander peoples Professional publication - NPS RADAR - Brief item | The authority listing for terbinafine 250 mg tablets was extended o allow the treatment of Aboriginal and Torres Strait Islander peoples with a dermatophyte infection that has not responded to topical treatment. |
| Pioglitazone (Actos) for type 2 diabetes mellitus Professional publication - NPS RADAR - Review | Information on use of pioglitazone (Actos) for type 2 diabetes mellitus, including safety and dosing issues. |
| Fentanyl lozenges (Actiq) for breakthrough cancer pain Professional publication - NPS RADAR - Review | Information on use of fentanyl lozenges (Actiq) for breakthrough cancer pain, including safety concerns and dosing issues. |
| Paliperidone (Invega) for schizophrenia Professional publication - NPS RADAR - Review | Information on use of paliperidone (Invega) for schizophrenia, including safety and dosing issues. |
| Intolerance and contraindications to metformin Professional publication - NPS RADAR - Web only item | Lists adverse effects of and contraindications to metformin, including gastrointestinal symptoms, lactic acidosis, and renal impairment. |
| New York Heart Association grading of heart failure (NYHA) Professional publication - NPS RADAR - Web only item | Provides New York Heart Association grading of heart failure (NYHA) as additional content to pioglitazone use for type 2 diabetes mellitus. |
Complete list of all NPS RADAR content.
Find out more about NPS RADAR.
Date published: 2008-04-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
